What is Cyclerion Therapeutics, Inc. Common Stock's Market Cap?

Cyclerion Therapeutics, Inc. Common Stock's Market Cap is $15.7M, based on as-reported figures from SEC (XBRL) filings.

What is Cyclerion Therapeutics, Inc. Common Stock's Price / Sales?

Cyclerion Therapeutics, Inc. Common Stock's Price / Sales is 8.3×, based on as-reported figures from SEC (XBRL) filings.

What is Cyclerion Therapeutics, Inc. Common Stock's Revenue (TTM)?

Cyclerion Therapeutics, Inc. Common Stock's Revenue (TTM) is $1.9M, based on as-reported figures from SEC (XBRL) filings.

What is Cyclerion Therapeutics, Inc. Common Stock's Net Income (TTM)?

Cyclerion Therapeutics, Inc. Common Stock's Net Income (TTM) is -$6.7M, based on as-reported figures from SEC (XBRL) filings.

What is Cyclerion Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Cyclerion Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.43, based on as-reported figures from SEC (XBRL) filings.

Cyclerion Therapeutics, Inc. Common Stock (CYCN) Financial Statements

Cyclerion Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00KXXHZ46

XNAS · usd

3.36▼ 0.89 (-20.94%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt—

Trading Information

Previous Close4.25

Day's Range2.82 – 3.84

52-Week Range1.01 – 8.48

Volume435.6K

Avg Volume68.1K

Share Statistics

Shares Outstanding

Employees1

ExchangeXNAS

Listed2019-03-18

Share count as of August 4, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Cyclerion Therapeutics, Inc. Common Stock (CYCN)

What is Cyclerion Therapeutics, Inc. Common Stock's Market Cap?: Cyclerion Therapeutics, Inc. Common Stock's Market Cap is $15.7M, based on as-reported figures from SEC (XBRL) filings.
What is Cyclerion Therapeutics, Inc. Common Stock's Price / Sales?: Cyclerion Therapeutics, Inc. Common Stock's Price / Sales is 8.3×, based on as-reported figures from SEC (XBRL) filings.
What is Cyclerion Therapeutics, Inc. Common Stock's Revenue (TTM)?: Cyclerion Therapeutics, Inc. Common Stock's Revenue (TTM) is $1.9M, based on as-reported figures from SEC (XBRL) filings.
What is Cyclerion Therapeutics, Inc. Common Stock's Net Income (TTM)?: Cyclerion Therapeutics, Inc. Common Stock's Net Income (TTM) is -$6.7M, based on as-reported figures from SEC (XBRL) filings.
What is Cyclerion Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Cyclerion Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.43, based on as-reported figures from SEC (XBRL) filings.